199 related articles for article (PubMed ID: 33098668)
41. Circulating PD-1
Zhang L; Li H; Ren H; Hu P
Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
[TBL] [Abstract][Full Text] [Related]
42. Investigating the role of circulating CXCR5-expressing CD8+ T-cells as a biomarker for bacterial infection in subjects with pneumonia.
Shen Y; Qu QX; Jin MN; Chen C
Respir Res; 2019 Mar; 20(1):54. PubMed ID: 30866951
[TBL] [Abstract][Full Text] [Related]
43.
Wang B; Zhang W; Jankovic V; Golubov J; Poon P; Oswald EM; Gurer C; Wei J; Ramos I; Wu Q; Waite J; Ni M; Adler C; Wei Y; Macdonald L; Rowlands T; Brydges S; Siao J; Poueymirou W; MacDonald D; Yancopoulos GD; Sleeman MA; Murphy AJ; Skokos D
Sci Immunol; 2018 Nov; 3(29):. PubMed ID: 30389797
[TBL] [Abstract][Full Text] [Related]
44. Role of PD-1 during effector CD8 T cell differentiation.
Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the relationship between de-novo DSA development and CXCR5+PD-1+CD8+ T cells and PD-1/PD-L1 mRNA expression in kidney transplant recipients.
Ekinci NS; Yilmaz VT; Kilinc Y; Kocak H; Darbas S; Kisaoglu A; Aydinli B; Uzuner SY; Ucar F
Clin Transplant; 2023 Nov; 37(11):e15104. PubMed ID: 37589946
[TBL] [Abstract][Full Text] [Related]
46. Frequency and functional characterization of exhausted CD8
Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
[TBL] [Abstract][Full Text] [Related]
47. Transforming growth factor-β promotes the function of HIV-specific CXCR5
Yang HG; Jiao YM; Huang HH; Zhang C; Zhang JY; Xu RN; Song JW; Fan X; Jin L; Shi M; Wang FS
Microbiol Immunol; 2020 Jun; 64(6):458-468. PubMed ID: 32221997
[TBL] [Abstract][Full Text] [Related]
48. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract][Full Text] [Related]
49. Analysis of TCR Repertoire and PD-1 Expression in Decidual and Peripheral CD8
Morita K; Tsuda S; Kobayashi E; Hamana H; Tsuda K; Shima T; Nakashima A; Ushijima A; Kishi H; Saito S
Front Immunol; 2020; 11():1082. PubMed ID: 32582176
[TBL] [Abstract][Full Text] [Related]
50. Lack of CD8
Horton BL; Morgan DM; Momin N; Zagorulya M; Torres-Mejia E; Bhandarkar V; Wittrup KD; Love JC; Spranger S
Sci Immunol; 2021 Oct; 6(64):eabi8800. PubMed ID: 34714687
[TBL] [Abstract][Full Text] [Related]
51. CXCR5
Jiang H; Li L; Han J; Sun Z; Rong Y; Jin Y
DNA Cell Biol; 2017 Apr; 36(4):321-327. PubMed ID: 28157399
[TBL] [Abstract][Full Text] [Related]
52. Dichotomous Roles of Programmed Cell Death 1 on HIV-Specific CXCR5
Jiao YM; Yang HG; Huang HH; Tu B; Xing SJ; Mao L; Xia W; He R; Zhang JY; Xu RN; Jin L; Shi M; Xu Z; Qin EQ; Wang XC; Wu H; Ye L; Wang FS
Front Immunol; 2017; 8():1786. PubMed ID: 29312314
[TBL] [Abstract][Full Text] [Related]
53. Role of CXCR5
Zhou J; He X; Ou Y; Peng S; Li D; Zhou Q; Fu J; Long Y; Tan Y
J Viral Hepat; 2023 Aug; 30(8):638-645. PubMed ID: 37129474
[TBL] [Abstract][Full Text] [Related]
54. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
[TBL] [Abstract][Full Text] [Related]
55. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
56. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
57. IL-27 promotes the expansion of self-renewing CD8
Huang Z; Zak J; Pratumchai I; Shaabani N; Vartabedian VF; Nguyen N; Wu T; Xiao C; Teijaro JR
J Exp Med; 2019 Aug; 216(8):1791-1808. PubMed ID: 31164392
[TBL] [Abstract][Full Text] [Related]
58. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles.
Quigley MF; Gonzalez VD; Granath A; Andersson J; Sandberg JK
Eur J Immunol; 2007 Dec; 37(12):3352-62. PubMed ID: 18000950
[TBL] [Abstract][Full Text] [Related]
59. Circulating CXCR5
Ekman I; Ihantola EL; Viisanen T; Rao DA; Näntö-Salonen K; Knip M; Veijola R; Toppari J; Ilonen J; Kinnunen T
Diabetologia; 2019 Sep; 62(9):1681-1688. PubMed ID: 31270583
[TBL] [Abstract][Full Text] [Related]
60. CXCR5
Tang J; Zha J; Guo X; Shi P; Xu B
Int Immunopharmacol; 2017 Sep; 50():146-151. PubMed ID: 28662433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
